1D NMR (1H, 13C)

Heparin analysis

Therapeutic Modalities:

Biologics

Development Phases:

Research, Preclinical, Early-phase Clinical, Late-Phase Clinical, Commercial

Quality Standard:

non-GMP (ISO 9001:2015) (Spectralservice) and GMP (Spectralservice)

Pharmacopoeia:

EP 07/2024:0333; EP 07/2024:0332; EP 07/2023:0828 USP: Monograph: Heparin Sodium ; USP: Monograph: Dalteparin Sodium; USP: Monograph: Polyoxyl 20 Cetostearyl Ether